CLINICAL_TRIALS
research
· 2017-05-22
Clinical Trial Update: A Feasibility Trial to Evaluate the Senseonics Continuous Glucose Monitoring System in Canada [NA]
Summary
Feasibility trial update for the Senseonics continuous glucose monitoring system in Canada evaluating its use in diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Senseonics, Inc. | Conditions: Diabetes Mellitus | NA | Status: UNKNOWN